Improvement of Skin Penetration, Antipollutant Activity and Skin Hydration of 7,3',4'-Trihydroxyisoflavone Cyclodextrin Inclusion Complex

Overview

Journal Pharmaceutics

Publisher MDPI

Date 2019 Aug 11

PMID 31398912

Citations 10

Authors

Pao Hsien Huang

Stephen Chu Sung Hu

Feng Lin Yen

Chih Hua Tseng

Affiliations

Soon will be listed here.

Abstract

As is known, many antioxidants from plant extracts have been used as additives in skincare products to prevent skin damage following overexposure to environmental pollutants. 7,3',4'-trihydroxyisoflavone (734THIF), an isoflavone compound, possesses various biological activities, including antioxidant, antityrosinase, photodamage protection, and anticancer effects. Unfortunately, 734THIF has poor water solubility, which limits its skin penetration and absorption, and subsequently influences its biological activity. The aim of the present study was to investigate the mechanisms for the improvement in water solubility and skin penetration of 2-hydroxypropyl-β-cyclodextrin (HPBCD) inclusion complex with 734THIF (5-7HP). We also determined its photostability, antipollutant activity in HaCaT keratinocytes, and moisturizing effect in human subjects. Our results showed that 734THIF was embedded into the lipophilic inner cavity of HPBCD and its water solubility and skin penetration were thereby improved through amorphous transformation, surface area enhancement, and hydrogen bonding formation between 734THIF and HPBCD. In addition, 5-7HP inhibited PM-induced ROS generation and then downregulated ROS-mediated COX-2 and MMP9 production and AQP-3 consumption by inhibiting the phosphorylation of MAPKs. Consequently, we suggest that 5-7HP is a safe and photostable topical ingredient to enhance the skin penetration of 734THIF and skin hydration, and therefore 5-7HP may be used as an antipollutant additive in skin care products.

Citing Articles

Preparation, solubility, and anti-inflammatory effects of a complex of diphenylcyclopropenone/β-cyclodextrin derivatives as the treatment of alopecia areata.

Inoue Y, Yoshino K, Kudo S, Kodama N, Moteki H, Kimura M J Pharm Pharm Sci. 2024; 27:13230.

PMID: 39193564 PMC: 11348807. DOI: 10.3389/jpps.2024.13230.

Myricetin Nanofibers Enhanced Water Solubility and Skin Penetration for Increasing Antioxidant and Photoprotective Activities.

Lin T, Yang C, Wu T, Tseng C, Yen F Pharmaceutics. 2023; 15(3).

PMID: 36986766 PMC: 10058934. DOI: 10.3390/pharmaceutics15030906.

Antioxidant, Anti-Inflammation and Antiaging Activities of Methanolic Extract on Urban Particulate Matter-Induced HaCaT Keratinocytes Damage.

Yang C, Pan C, Tseng C, Yen F Antioxidants (Basel). 2022; 11(11).

PMID: 36421490 PMC: 9687219. DOI: 10.3390/antiox11112304.

Enhancement of Dissolving Capacity and Reducing Gastric Mucosa Irritation by Complex Formation of Resibufogenin with β-Cyclodextrin or 2-Hydroxypropyl-β-cyclodextrin.

Liu N, Chen H, Yang Z, Xia M, Wang D, Zang L Molecules. 2022; 27(10).

PMID: 35630687 PMC: 9146005. DOI: 10.3390/molecules27103213.

Therapeutic efficacy of an injectable formulation of purinostat mesylate in SU-DHL-6 tumour model.

Zhu Z, Wen J, Xu Y, Pei H, Li D, Tang M Ann Med. 2022; 54(1):743-753.

PMID: 35243950 PMC: 8903780. DOI: 10.1080/07853890.2022.2045347.

References

Sougrat R, Morand M, Gondran C, Barre P, Gobin R, Bonte F . Functional expression of AQP3 in human skin epidermis and reconstructed epidermis. J Invest Dermatol. 2002; 118(4):678-85. DOI: 10.1046/j.1523-1747.2002.01710.x. View

Hara M, Ma T, Verkman A . Selectively reduced glycerol in skin of aquaporin-3-deficient mice may account for impaired skin hydration, elasticity, and barrier recovery. J Biol Chem. 2002; 277(48):46616-21. DOI: 10.1074/jbc.M209003200. View

DITTERT L, Higuchi T, Reese D . PHASE SOLUBILITY TECHNIQUE IN STUDYING THE FORMATION OF COMPLEX SALTS OF TRIAMTERENE. J Pharm Sci. 1964; 53:1325-8. DOI: 10.1002/jps.2600531108. View

Loftsson T, Jarho P, Masson M, Jarvinen T . Cyclodextrins in drug delivery. Expert Opin Drug Deliv. 2005; 2(2):335-51. DOI: 10.1517/17425247.2.1.335. View

Challa R, Ahuja A, Ali J, Khar R . Cyclodextrins in drug delivery: an updated review. AAPS PharmSciTech. 2005; 6(2):E329-57. PMC: 2750546. DOI: 10.1208/pt060243. View

Verdier-Sevrain S, Bonte F . Skin hydration: a review on its molecular mechanisms. J Cosmet Dermatol. 2007; 6(2):75-82. DOI: 10.1111/j.1473-2165.2007.00300.x. View

Pandya P, Gattani S, Jain P, Khirwal L, Surana S . Co-solvent evaporation method for enhancement of solubility and dissolution rate of poorly aqueous soluble drug simvastatin: in vitro-in vivo evaluation. AAPS PharmSciTech. 2008; 9(4):1247-52. PMC: 2628261. DOI: 10.1208/s12249-008-9176-z. View

Sardy M . Role of matrix metalloproteinases in skin ageing. Connect Tissue Res. 2009; 50(2):132-8. DOI: 10.1080/03008200802585622. View

Jimenez E, Linares C, Rodriguez L, Bleda M, Diaz J . Short-term impact of particulate matter (PM2.5) on daily mortality among the over-75 age group in Madrid (Spain). Sci Total Environ. 2009; 407(21):5486-92. DOI: 10.1016/j.scitotenv.2009.06.038. View

10.

Park J, Kim D, Lee J, Lee J, Kim D, Kim H . Natural ortho-dihydroxyisoflavone derivatives from aged Korean fermented soybean paste as potent tyrosinase and melanin formation inhibitors. Bioorg Med Chem Lett. 2009; 20(3):1162-4. DOI: 10.1016/j.bmcl.2009.12.021. View

11.

Sun Q, Hong X, Wold L . Cardiovascular effects of ambient particulate air pollution exposure. Circulation. 2010; 121(25):2755-65. PMC: 2924678. DOI: 10.1161/CIRCULATIONAHA.109.893461. View

12.

Vierkotter A, Schikowski T, Ranft U, Sugiri D, Matsui M, Kramer U . Airborne particle exposure and extrinsic skin aging. J Invest Dermatol. 2010; 130(12):2719-26. DOI: 10.1038/jid.2010.204. View

13.

Borghetti G, Pinto A, Lula I, Sinisterra R, Teixeira H, Bassani V . Daidzein/cyclodextrin/hydrophilic polymer ternary systems. Drug Dev Ind Pharm. 2011; 37(8):886-93. DOI: 10.3109/03639045.2010.548066. View

14.

Lee D, Lee K, Byun S, Jung S, Song N, Lim S . 7,3',4'-Trihydroxyisoflavone, a metabolite of the soy isoflavone daidzein, suppresses ultraviolet B-induced skin cancer by targeting Cot and MKK4. J Biol Chem. 2011; 286(16):14246-56. PMC: 3077626. DOI: 10.1074/jbc.M110.147348. View

15.

Jiang Y, Jiang X, Law K, Chen Y, Gu J, Zhang W . Enhanced anti-tumor effect of 9-nitro-camptothecin complexed by hydroxypropyl-β-cyclodextrin and safety evaluation. Int J Pharm. 2011; 415(1-2):252-8. DOI: 10.1016/j.ijpharm.2011.05.056. View

16.

Loftsson T, Brewster M . Cyclodextrins as functional excipients: methods to enhance complexation efficiency. J Pharm Sci. 2012; 101(9):3019-32. DOI: 10.1002/jps.23077. View

17.

Lee Y, Je Y, Lee S, Li Z, Choi D, Kwon Y . Changes in transepidermal water loss and skin hydration according to expression of aquaporin-3 in psoriasis. Ann Dermatol. 2012; 24(2):168-74. PMC: 3346907. DOI: 10.5021/ad.2012.24.2.168. View

18.

Lu Y, Guo T, Qi J, Zhang J, Wu W . Enhanced dissolution and stability of lansoprazole by cyclodextrin inclusion complexation: preparation, characterization, and molecular modeling. AAPS PharmSciTech. 2012; 13(4):1222-9. PMC: 3513431. DOI: 10.1208/s12249-012-9842-z. View

19.

Nguyen T, Liu B, Zhao J, Thomas D, Hook J . An investigation into the supramolecular structure, solubility, stability and antioxidant activity of rutin/cyclodextrin inclusion complex. Food Chem. 2012; 136(1):186-92. DOI: 10.1016/j.foodchem.2012.07.104. View

20.

Lane M . Skin penetration enhancers. Int J Pharm. 2013; 447(1-2):12-21. DOI: 10.1016/j.ijpharm.2013.02.040. View